Skip to content
Clinical Trials – home
ItalyBack to Italy

Clinical trials in Civitavecchia

5 clinical trials in Civitavecchia, Italy. Every trial is listed in the EU Clinical Trials Register and updated daily.

ItalyOur site in ItalyStudi-Clinici.it(opens in a new tab)
Civitavecchia at a glance
5
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

5 trials in Civitavecchia

Open in trial search
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Mps-102
  • Sponsor:Fondazione Ricerca Traslazionale
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:Fondazione Ricerca Traslazionale
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Dacomitinib
  • Sponsor:Fondazione Ricerca Traslazionale
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Dazodalibep
  • Sponsor:Horizon Therapeutics Ireland Designated Activity Company
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Gabapentin
  • Sponsor:Dompe' Farmaceutici S.p.A.

Other cities in Italy

The busiest research cities in the country

All 232 cities in Italy

Clinical research in Civitavecchia

What the registry says about research in the country

01 Rheumatology Research

Ongoing clinical investigations focused on Sjögren's Syndrome, evaluating novel therapeutic approaches for patients with moderate to severe systemic manifestations. Research aims to assess treatment safety and effectiveness in managing autoimmune symptoms.

  • Systemic Disease Management
  • Autoimmune Disorder Treatment
  • Long-term Safety Studies

Current trials are exploring the potential of dazodalibep in addressing various manifestations of the condition.

02 Oncology Studies

Advanced research in non-small-cell lung cancer treatment, particularly focusing on metastatic cases and targeted therapies. Studies are evaluating various drug combinations and sequences to optimize patient outcomes.

  • EGFR Mutation-Positive NSCLC
  • Second-line Therapy Options
  • Brain Metastases Management

Innovative approaches combining immunotherapy with traditional treatments are being investigated.

03 Pain Management Research

Clinical trials examining new therapeutic options for chronic low back pain, comparing novel compounds with established treatments. Research focuses on analgesic effectiveness and safety profiles.

  • Analgesic Development
  • Comparative Pain Studies
  • Oral Treatment Options

Studies are evaluating different dosage levels to determine optimal pain management strategies.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.